Galmed Pharmaceuticals (GLMD) Short Interest Ratio & Short Volume $1.81 +0.02 (+1.12%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$1.80 -0.02 (-0.83%) As of 06/27/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Galmed Pharmaceuticals Short Interest DataGalmed Pharmaceuticals (GLMD) has a short interest of 66,900 shares, representing 3.05% of the float (the number of shares available for trading by the public). This marks a -64.97% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1.33 million shares to cover all short positions.Current Short Interest66,900 sharesPrevious Short Interest191,000 sharesChange Vs. Previous Month-64.97%Dollar Volume Sold Short$107.04 thousandShort Interest Ratio0.0 Days to CoverLast Record DateJune 15, 2025Outstanding Shares1,650,000 sharesFloat Size2,190,000 sharesShort Percent of Float3.05%Today's Trading Volume112,210 sharesAverage Trading Volume1,329,825 sharesToday's Volume Vs. Average8% Short Selling Galmed Pharmaceuticals? Sign up to receive the latest short interest report for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGLMD Short Interest Over TimeGLMD Days to Cover Over TimeGLMD Percentage of Float Shorted Over Time Galmed Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202566,900 shares $107.04 thousand -65.0%3.1%0 $1.60 5/31/2025191,000 shares $275.04 thousand +1.5%8.6%0.1 $1.44 5/15/2025188,200 shares $237.13 thousand -54.8%8.5%0.1 $1.26 4/30/2025416,100 shares $540.93 thousand +331.6%18.7%0.2 $1.30 4/15/202596,400 shares $135.92 thousand +41.4%4.3%0.1 $1.41 3/31/202568,200 shares $98.21 thousand +40.6%3.1%0.1 $1.44 3/15/202548,500 shares $83.75 thousand +889.8%3.0%0.1 $1.73 2/28/20254,900 shares $10.65 thousand +19.5%0.3%0.1 $2.17 2/15/20254,100 shares $10.50 thousand -39.7%0.3%0.1 $2.56 1/31/20256,800 shares $19.07 thousand +13.3%0.4%0.2 $2.81 Get the Latest News and Ratings for GLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20256,000 shares $16.74 thousand -41.2%0.4%0.1 $2.79 12/31/202410,200 shares $32.54 thousand -31.1%0.6%0.1 $3.19 12/15/202414,800 shares $43.96 thousand -35.1%0.9%0.1 $2.97 11/30/202422,800 shares $65.21 thousand +31.0%1.4%0 $2.86 11/15/202417,400 shares $50.98 thousand -62.1%1.1%0 $2.93 10/31/202445,900 shares $153.31 thousand +73.9%3.1%0 $3.34 10/15/202426,400 shares $103.49 thousand -22.8%1.8%0 $3.92 9/30/202434,200 shares $234.61 thousand +9.6%2.3%0 $6.86 9/15/202431,200 shares $128.23 thousand -23.2%5.0%0 $4.11 8/31/202440,600 shares $137.23 thousand +235.5%6.6%0.8 $3.38 8/15/202412,100 shares $3.63 thousand +17.5%0.2%0 $0.30 7/31/202410,300 shares $3.17 thousand +14.4%0.2%0.2 $0.31 7/15/20249,000 shares $2.72 thousand +1,185.7%0.2%0.2 $0.30 6/30/2024700 shares $192.50 -94.9%0.0%0 $0.28 6/15/202413,700 shares $4.56 thousand -42.4%0.2%0.1 $0.33 5/31/202423,800 shares $8.81 thousand -67.3%0.4%0.1 $0.37 5/15/202472,800 shares $27.92 thousand -13.1%1.3%0.4 $0.38 4/30/202483,800 shares $29.50 thousand +6.1%1.5%0.4 $0.35 4/15/202479,000 shares $30.01 thousand +101.5%2.2%0.4 $0.38 3/31/202439,200 shares $13.57 thousand +532.3%1.1%0.2 $0.35 3/15/20246,200 shares $1.89 thousand -84.9%0.2%0 $0.31 2/29/202441,000 shares $16.32 thousand -46.1%1.2%0.4 $0.40 2/15/202476,000 shares $28.89 thousand +560.9%2.1%0.6 $0.38 1/31/202411,500 shares $4.31 thousand -79.1%0.3%0.1 $0.37 1/15/202455,100 shares $25.02 thousand -9.7%1.5%0.3 $0.45 12/31/202361,000 shares $27.76 thousand +65.3%1.7%0.4 $0.46 12/15/202336,900 shares $13.17 thousand -56.9%1.0%0.2 $0.36 11/30/202385,700 shares $30.42 thousand +564.3%2.4%0.4 $0.36 11/15/202312,900 shares $5.16 thousand +17.3%0.4%0.1 $0.40 10/31/202311,000 shares $4.18 thousand -1.8%0.3%0.2 $0.38New Rule Hits in July — The Smart Money Already Moved (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 10/15/202311,200 shares $4.59 thousand +75.0%0.3%0.1 $0.41 9/30/20236,400 shares $3.97 thousand +88.2%0.2%0 $0.62 9/15/20233,400 shares $2.52 thousand -52.8%0.1%0 $0.74 8/31/20237,200 shares $5.82 thousand -32.7%0.2%0 $0.81 8/15/202310,700 shares $8.67 thousand -61.1%0.3%0 $0.81 7/31/202327,500 shares $31.63 thousand -92.3%1.5%0.1 $1.15 7/15/2023357,100 shares $517.80 thousand +2,668.2%20.1%1.3 $1.45 6/30/202312,900 shares $37.54 thousand -6.5%0.9%0.1 $2.91 6/15/202313,800 shares $51.47 thousand -14.3%1.0%0.5 $3.73 5/31/202316,100 shares $74.22 thousand -18.7%1.1%0.7 $4.61 5/15/202319,800 shares $0.00 +1,700.0%1.4%0.9 $0.00 4/30/202317,200 shares $5.33 thousand -6.5%0.1%0.1 $0.31 4/15/202318,400 shares $5.70 thousand -30.3%0.1%0.3 $0.31 3/31/202326,400 shares $11.26 thousand -28.5%0.1%0.3 $0.43 3/15/202336,900 shares $17.24 thousand +58.4%0.2%0.3 $0.47 2/28/202323,300 shares $11.18 thousand -32.1%0.1%0.2 $0.48 2/15/202334,300 shares $20.92 thousand +106.6%0.2%0.2 $0.61 1/31/202316,600 shares $10.97 thousand -88.4%0.1%0.1 $0.66 1/15/2023143,500 shares $115.06 thousand -2.3%0.7%1.1 $0.80 12/30/2022146,900 shares $73.45 thousand +57.3%0.7%1.3 $0.50 12/15/202293,400 shares $27.09 thousand +233.6%0.4%1.1 $0.29 11/30/202228,000 shares $8.17 thousand +53.0%0.1%0.8 $0.29 11/15/202218,300 shares $6.10 thousand -45.9%0.1%0.4 $0.33 10/31/202233,800 shares $12.85 thousand +80.8%0.2%0.6 $0.38 10/15/202218,700 shares $7.26 thousand +22.2%0.1%0.3 $0.39 9/30/202215,300 shares $4.76 thousand -57.5%0.1%0.2 $0.31 9/15/202236,000 shares $16.56 thousand -35.5%0.2%0.4 $0.46 8/31/202255,800 shares $25.90 thousand +234.1%0.3%0.5 $0.46 8/15/202216,700 shares $7.42 thousand -34.0%0.1%0.2 $0.44 7/31/202225,300 shares $12.70 thousand -29.3%0.1%0.2 $0.50 7/15/202235,800 shares $21.65 thousand -66.4%0.2%0.3 $0.60 6/30/2022106,600 shares $69.29 thousand -0.7%0.5%0.9 $0.65 6/15/2022107,300 shares $48.29 thousand +364.5%0.5%1.1 $0.45 5/31/202223,100 shares $11.82 thousand -0.4%0.1%0.2 $0.51 5/15/202223,200 shares $14.11 thousand -27.3%0.1%0.3 $0.61 4/30/202231,900 shares $52.95 thousand -37.6%0.2%0.4 $1.66 4/15/202251,100 shares $83.29 thousand -6.2%0.2%0.9 $1.63 3/31/202254,500 shares $86.66 thousand -47.3%0.3%0.5 $1.59 3/15/2022103,500 shares $127.31 thousand -36.0%0.5%0.8 $1.23 2/28/2022161,700 shares $232.85 thousand -30.9%0.8%1.2 $1.44 2/15/2022234,100 shares $374.56 thousand -17.9%1.1%1.7 $1.60 1/31/2022285,200 shares $462.02 thousand +21.7%1.3%1.8 $1.62 1/15/2022234,300 shares $374.88 thousand +20.5%N/A1.3 $1.60 12/31/2021194,400 shares $353.81 thousand -36.4%1.0%1.1 $1.82 12/15/2021305,500 shares $653.77 thousand +7.0%1.5%2.5 $2.14 11/30/2021285,600 shares $719.71 thousand -15.6%1.4%2.4 $2.52 11/15/2021338,500 shares $1.01 million +24.6%1.7%2.7 $2.98 10/29/2021271,700 shares $671.10 thousand -16.9%1.3%2.2 $2.47 10/15/2021326,900 shares $898.98 thousand +2.7%1.6%1.4 $2.75 9/30/2021318,300 shares $888.06 thousand -17.0%1.6%1.4 $2.79New Rule Hits in July — The Smart Money Already Moved (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 9/15/2021383,700 shares $1.12 million -10.8%1.9%1.6 $2.91 8/31/2021430,100 shares $1.41 million -8.0%2.1%1.7 $3.27 8/13/2021467,500 shares $1.38 million -28.5%2.3%1.4 $2.95 7/30/2021654,000 shares $1.63 million +0.8%3.3%1.8 $2.49 7/15/2021648,700 shares $1.69 million -0.6%3.2%2.4 $2.61 6/30/2021652,500 shares $1.98 million +23.6%3.3%2.3 $3.04 6/15/2021527,900 shares $1.68 million +97.9%2.6%1.8 $3.18 5/28/2021266,800 shares $693.68 thousand -1.4%1.3%0.8 $2.60 5/14/2021270,700 shares $606.37 thousand -16.4%1.4%1 $2.24 4/30/2021323,900 shares $1.09 million -2.4%1.6%0.8 $3.37 4/15/2021331,700 shares $1.09 million +15.1%1.7%0.8 $3.30 3/31/2021288,300 shares $960.04 thousand +30.2%1.5%0.7 $3.33 3/15/2021221,500 shares $775.25 thousand +14.8%1.1%0.5 $3.50 2/26/2021192,900 shares $792.82 thousand +389.6%1.1%0.5 $4.11 2/12/202139,400 shares $212.76 thousand +4.2%0.2%0.1 $5.40 1/29/202137,800 shares $142.70 thousand +49.4%0.2%0.2 $3.78 1/15/202125,300 shares $88.04 thousand -22.6%0.2%0.2 $3.48 12/31/202032,700 shares $106.93 thousand +26.3%0.2%0.3 $3.27 12/15/202025,900 shares $94.79 thousand -29.0%0.2%0.3 $3.66 11/30/202036,500 shares $152.21 thousand +55.3%0.2%0.5 $4.17 11/15/202023,500 shares $79.67 thousand +109.8%0.2%0.3 $3.39 10/30/202011,200 shares $34.38 thousand -49.6%0.1%0.2 $3.07 10/15/202022,200 shares $74.37 thousand -53.0%0.1%0.3 $3.35 9/30/202047,200 shares $166.62 thousand -28.9%0.3%0.5 $3.53 9/15/202066,400 shares $278.88 thousand -65.2%0.4%0.8 $4.20 8/31/2020191,000 shares $932.08 thousand -56.7%1.2%2.3 $4.88 8/14/2020441,500 shares $2.09 million -3.0%2.8%5.1 $4.74 7/31/2020455,100 shares $2.21 million -2.5%2.9%4.6 $4.85 7/15/2020466,700 shares $2.20 million +0.3%3.2%5.2 $4.72 6/30/2020465,500 shares $2.25 million +23.8%3.2%5.8 $4.84 GLMD Short Interest - Frequently Asked Questions What is Galmed Pharmaceuticals' current short interest? Short interest is the volume of Galmed Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 66,900 shares of GLMD short. 3.05% of Galmed Pharmaceuticals' shares are currently sold short. Learn More on Galmed Pharmaceuticals' current short interest. What is a good short interest percentage for Galmed Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.05% of Galmed Pharmaceuticals' floating shares are currently sold short. Is Galmed Pharmaceuticals' short interest increasing or decreasing? Galmed Pharmaceuticals saw a decrease in short interest during the month of June. As of June 15th, there was short interest totaling 66,900 shares, a decrease of 65.0% from the previous total of 191,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Galmed Pharmaceuticals' float size? Galmed Pharmaceuticals currently has issued a total of 1,650,000 shares. Some of Galmed Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Galmed Pharmaceuticals currently has a public float of 2,190,000 shares. How does Galmed Pharmaceuticals' short interest compare to its competitors? 3.05% of Galmed Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Galmed Pharmaceuticals: Eyenovia, Inc. (4.05%), AlloVir, Inc. (2.56%), Athira Pharma, Inc. (4.39%), Equillium, Inc. (11.89%), Citius Pharmaceuticals, Inc. (12.82%), Bright Green Co. (0.04%), Phio Pharmaceuticals Corp. (5.09%), BioCardia, Inc. (0.35%), Ainos, Inc. (36.64%), Trinity Biotech PLC (0.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Galmed Pharmaceuticals stock? Short selling GLMD is an investing strategy that aims to generate trading profit from Galmed Pharmaceuticals as its price is falling. GLMD shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Galmed Pharmaceuticals? A short squeeze for Galmed Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GLMD, which in turn drives the price of the stock up even further. How often is Galmed Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLMD, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Eyenovia Short Interest Data AlloVir Short Interest Data Athira Pharma Short Interest Data Equillium Short Interest Data Citius Pharmaceuticals Short Interest Data Bright Green Short Interest Data Phio Pharmaceuticals Short Interest Data BioCardia Short Interest Data Ainos Short Interest Data Trinity Biotech Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GLMD) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… And it's all thanks to President Trump. His ...InvestorPlace | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored“Trump’s 24-Hour Profit Windows” revealedTrading legend Larry Benedict has discovered a repeating surge of $240 billion (and more)... Flowing into a...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galmed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
